Casim A. Sarkar, PhD

faculty photo
Associate Professor of Bioengineering
Department: Bioengineering

Contact information
Education:
BS (Chemical Engineering)
University of Texas at Austin, 1997.
PhD (Chemical Engineering)
Massachusetts Institute of Technology, 2002.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Please see http://www.seas.upenn.edu/~caslab/ for further information.

Selected Publications

Santhosh Palani and Casim A. Sarkar: Integrating extrinsic and intrinsic cues into a minimal model of lineage commitment for hematopoietic progenitors. PLoS Computational Biology 5(9): e1000518, Sep 2009.

Peter Milovnik, Davide Ferrari, Casim A. Sarkar, and Andreas Plückthun: Selection and characterization of DARPins specific for the neurotensin receptor 1. Protein Engineering, Design & Selection 22(6): 357-66, Jun 2009.

Casim A. Sarkar, Igor Dodevski, Manca Kenig, Stefan Dudli, Anja Mohr, Emmanuel Hermans, and Andreas Plückthun: Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity. Proceedings of the National Academy of Sciences of the United States of America 105(39): 14808-13, Sep 2008.

Santhosh Palani and Casim A. Sarkar: Positive receptor feedback during lineage commitment can generate ultrasensitivity to ligand and confer robustness to a bistable switch. Biophysical Journal 95(4): 1575-89, Aug 2008.

Susanne Kubetzko, Casim A. Sarkar, and Andreas Plückthun: Protein PEGylation decreases observed target association rates via a dual blocking mechanism. Molecular Pharmacology 68(5): 1439-54, Nov 2005.

Casim A. Sarkar, Ky Lowenhaupt, Peggy J. Wang, Thomas Horan, and Douglas A. Lauffenburger: Parsing the effects of binding, signaling, and trafficking on the mitogenic potencies of granulocyte colony-stimulating factor analogues. Biotechnology Progress 19(3): 955-64, May-Jun 2003.

Margaret S. Ricci, Casim A. Sarkar, Eric M. Fallon, Douglas A. Lauffenburger, and David N. Brems: pH Dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factor. Protein Science 12(5): 1030-8, May 2003.

Casim A. Sarkar and Douglas A. Lauffenburger: Cell-level pharmacokinetic model of granulocyte colony-stimulating factor: implications for ligand lifetime and potency in vivo. Molecular Pharmacology 63(1): 147-58, Jan 2003.

Casim A. Sarkar, Ky Lowenhaupt, Thomas Horan, Thomas C. Boone, Bruce Tidor, and Douglas A. Lauffenburger: Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching". Nature Biotechnology 20(9): 908-13, Sep 2002.

back to top
Last updated: 01/08/2010
The Trustees of the University of Pennsylvania